Table 3.
Albuterol | Saline | |||
Pre | Post | Pre | Post | |
PTEF (ml/s) | 93.8 ± 28.4* | 101.3 ± 28.5* | 95.3 ± 25.1* | 105.0 ± 30.5* |
VT (ml/kg) | 6.4 ± 1.5 | 6.8 ± 1.3 | 6.9 ± 2.3 | 7.4 ± 3.5 |
tPTEF/tE | 0.16 ± 0.09 | 0.13 ± 0.05 | 0.16 ± 0.08 | 0.14 ± 0.08 |
VPTEF/VE | 0.22 ± 0.11 | 0.20 ± 0.06 | 0.22 ± 0.08 | 0.21 ± 0.07 |
TEF10 (ml/s) | 39 ± 13.0* | 33 ± 13.2* | 43 ± 17.7 | 39 ± 18.2 |
TEF25 (ml/s) | 55 ± 16.0 | 48 ± 16.9 | 57 ± 21.7 | 56 ± 19.4 |
TEF50 (ml/s) | 77 ± 22 | 78 ± 25 | 77 ± 24* | 83 ± 23* |
25/PT | 0.59 ± 0.15* | 0.48 ± 0.13* | 0.60 ± 0.19 | 0.53 ± 0.15 |
Data presented as mean ± standard deviation. PTEF, peak tidal expiratory flow; VT, tidal volume per kilogram of body weight; tPTEF/tE, ratio of time to peak expiratory flow to total expiratory time; VPTEF/VE, ratio of exhaled volume to peak expiratory flow to tidal volume; TEF10, TEF25, and TEF50, tidal expiratory flow rates at 10%, 25%, and 50% of the remaining tidal volume; 25/PT, ratio of TEF25 to the PTEF. *P < 0.05 between pre and post values.